Volume 29 - Issue 1 - January 2021

Zola M. N’Dandu, MD, Interventional Cardiology Head Section, and Deshinee Mcglothlin, RN, BSN, MHA, Regional Nursing Director of Cardiology/Cath Lab, Kenner, Louisiana

Nachiket J. Patel,^1,2 MD, FACC, FACP, FSCAI; Michael D. Barry,² DO, FACC; Stuart C. Lipskind,² MD; Charles Jost,² MD, FACC

Eric A. Osborn, MD, PhD

Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Ryan Graver, Vice President for Market Access at Terumo Business Edge

Mark Domyahn, Partner, JD LYMON

Richard Casazza, MAS, RT(CI)(R); Chaya Levine, MD; Pratik Mondal, MD; Enrico Montagna, RT(R)(CI); and Jamie Meng, MD

Maimonides Medical Center, Brooklyn, New York 

Pradnya Brijmohan Bhattad,¹ MD; Saroj Khadka,² MD; Timir K. Paul,³ MD, PhD, MPH, FACC, FSCAI, FAHA

Morton J. Kern, MD, with contributions from Steven R. Bailey, MD, Shreveport, Louisiana; Malcolm R. Bell, MD, Rochester, Minnesota; James C. Blankenship, MD, Albuquerque, New Mexico; Sam Butman, MD, Cottonwood, Arizona; David J. Cohen, MD, MSc, Kansas City, Missouri; Mauricio G. Cohen, MD, Miami, Florida; Timothy D. Henry, MD, Cincinnati, Ohio; Nils P. Johnson, MD, MS, Houston, Texas; Lloyd Klein, MD, Sonoma, California; Mitchell W. Krucoff, MD, Raleigh, North Carolina; Kreton Mavromatis, MD, Atlanta, Georgia; Sunil V. Rao, MD, Raleigh, North Carolina; Barry F. Uretsky, MD, Little Rock, Arkansas.